期刊文献+

VEGF、MMP-2、MMP-9在卵巢原发性与转移性癌中表达的研究 被引量:2

Different expressions of VEGF、MMP-2、MMP-9 in ovarian primary and secondary carcinoma
下载PDF
导出
摘要 目的 :探讨VEGF、MMP 2、MMP 9在卵巢原发上皮癌、库肯勃氏瘤中的表达差异及临床病理意义。方法 :采用免疫组化S P染色技术对 83例卵巢癌 (卵巢原发癌 4 5例、库肯勃氏瘤 38例 )进行分析 ,观察VEGF、MMP 2、MMP 9在卵巢癌中的表达。结果 :VEGF在卵巢原发癌和库肯勃氏瘤组织中的表达显著高于正常卵巢组织 (P <0 .0 5 ) ;MMP 2、MMP 9在正常卵巢组织中表达缺如 ;VEGF、MMP 2、MMP 9在卵巢原发癌与库肯勃氏瘤中表达均有显著差异 (P <0 .0 5 ) ;VEGF、MMP 2、MMP 9在库肯勃氏瘤中及卵巢原发癌中 ,任意两指标阳性表达均有正相关性 (P <0 .0 5 )。结论 :VEGF、MMP 2、MMP 9在库肯勃氏瘤的形成机制中起重要作用 ,与肿瘤的浸润转移密切相关 。 Objective:To investigate the different expressions of vascular endothelial growth factor(VEGF) and metall proteinase(MMP 2、MMP 9) in ovarian primary carcinoma and secondary carcinoma.Methods:Streptavidin peroxidase immunohistochemistry was used to determine the expressions of VEGF,MMP 2,MMP 9 in 83 cases of ovarian carcinoma (45 of primary and 38 of Krukenberg tumors).Results:(1)the expression of VEGF was significantly different between primary ovarian carcinoma and Krukenberg tumors(P<0.05);(2)The expressions of MMP 2,MMP 9 in the every type of primary ovarian carcinomas was significantly different with that of Krukenberg tumors(P<0.05).Conclusion:All of VEGF、MMP 2 and MMP 9 are expressed in the primary ovarian carcinomas and Krukenberg tumors and have closely relationships with the invasion and metastasis.
出处 《现代妇产科进展》 CSCD 2004年第5期359-361,共3页 Progress in Obstetrics and Gynecology
基金 教育部出国留学人员资助课题 [2 0 0 3]4 0 6 黑龙江教育厅资助课题( 95 5 1138)
关键词 卵巢肿瘤 KRUKENBERG瘤 内皮生长因子 金属蛋白质酶类 Ovarian neoplasms Krukenberg tumor Endothelial growth-factors Metalloproteinases
  • 相关文献

参考文献9

  • 1郎景和 沈铿 向阳 主译.临床妇科肿瘤学[M](第6版)[M].北京:人民卫生出版社,2003.349.
  • 2Mori A, Ariis,Furutani M,et al.Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in HT1080 human fibrosarcoma cell model[J].Int J Cancer,1999,80:738-743
  • 3Garztti GG, Ciavattini A, Lucarini G, et al. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIBI immunostraining[J]. Gynecol Oncol, 1999, 73: 396-401
  • 4Gerber HP,Ferrara M. The role of VEGF in normal and neoplastic hematopoiesis[J].J Mol Med,2003,81(1):20-31
  • 5Kimura H,Konishi K,Kaji M,et al.Highly aggressive behavior and poor prognosis of small cell carcinoma in the stomach:flow cytometric and immunohistochemical analysis[J].Oncol Rep,1999,6(4):767-772
  • 6Hanemaaijer R, Verheijen J.Matrix metalloproteinase inhibitors: current developments and future perspectives[J].The Oncologist,2001,6:415-427
  • 7Sang QXA,Douglas DA.Computational sequence-analysis of matrix metaloproteinases[J].J Prot Chem,1996,4:393
  • 8Parsons SL, Watson SA, Collins HM, er al. Gelatinase (MMP-2和MMP-9) expression in gastrointestinal malignancy[J].Br J Cancer, 1998, 78,(11):1495-1502
  • 9卢运萍,张阿丽,王世宣,李静,王常玉,马丁.卵巢癌血管内皮生长因子过度表达及肿瘤浸润转移机制的探讨[J].中华妇产科杂志,2002,37(5):294-297. 被引量:25

共引文献24

同被引文献17

  • 1章文华,张蓉,李华,孙阳春,吴令英,白萍.23例CIN宫颈锥切术后再处理的初步分析[J].癌症进展,2005,3(1):65-68. 被引量:9
  • 2张师前,智绪亭,李家福.晚期卵巢癌理想肿瘤细胞减灭术的可行性研究[J].中国现代手术学杂志,2004,8(6):345-347. 被引量:2
  • 3钟朝晖,张华.138例妊娠滋养细胞疾病住院病例临床分析[J].中国妇幼保健,2005,20(10):1204-1206. 被引量:3
  • 4Orre M, Lotfi-Miri M, Mamers P, et al. Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary[J]. Br J Cancer, 1998,77(12) :2204 -2209.
  • 5DeCherney AH, Nathan L. CURRENT Obstetric & Gynecologic Diagnosis & Treatment [ M ]. 9ed. New York : McGraw-Hill Medical ,2003.
  • 6Hoekstra R, Eskens FA, Verweij J. Matrix metalloproteinase inhibitors: current developments and future perspectives [ J]. Oncologist,2001,6(5) :415 -427.
  • 7Lengyel E, Schmalfeldt B, Konik E. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer[J]. Gynecol Oncol, 2001, 82(2) :291 -298.
  • 8Weidner N, and Gasparini G. Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast careinoma patients [J]. Breast Cancer Res Treat, 1994, 29( 1 ) :97 - 107.
  • 9Raspollini MR, Amunni G, Villanucci A, et al. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma [J]. Int J Gynecol Cancer, 2004,14 ( 5 ) :815 - 823.
  • 10Sonmezer M, Gungor M, Ensari A, et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor [ J]. Int J Gynecol Cancer,2004,14 ( 1 ) :82 - 88.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部